1
Exhibit 24
POWER OF ATTORNEY
We, the undersigned directors of Duramed Pharmaceuticals, Inc., hereby
appoint E. Thomas Arington and Timothy J. Holt, or either of them, our true and
lawful attorneys and agents, to do any and all acts and things in our names and
on our behalf in our capacities indicated below, which said attorneys and
agents, or each of them, may deem necessary or advisable to enable said
corporation to comply with the Securities Exchange Act of 1934, as amended, and
any ruled, regulations and requirements of the Securities and Exchange
Commission, in connection with the corporation's Annual Report on Form 10-K for
the fiscal year ended December 31, 1998, including, without limitation, power
and authority to sign for us, or any of us, in our names in the capacities
indicated below, the Report and any and all amendments to the Report, and we
hereby ratify and confirm all that said attorneys and agents, or each of them,
shall do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, this Power of Attorney has been signed below by the following persons
as of the 31st day of March, 1999, in the capacities indicated:
Signature Title
--------- -----
Chairman of the Board
- - ----------------------------
E. Thomas Arington
Director
- - ----------------------------
Jeffrey T. Arington
/s/ George W. Baughman Director
- - ----------------------------
George W. Baughman
/s/ Peter R. Seaver Director
- - ----------------------------
Peter R. Seaver
Director
- - ----------------------------
S. Sundararaman